| 2025/0114,355 | TREATING LIVER DISEASE | May 09, 22 | Apr 10, 25 | Not available |
| 2025/0115,639 | HANGTAIMYCIN DERIVATIVES AND THEIR PREPARATION METHODS AND APPLICATION | Nov 22, 24 | Apr 10, 25 | WUHAN UNIVERSITY |
| 2025/0108,075 | METHODS OF ADMINISTERING COMPOSITIONS OF BACILLUS SUBTILIS PB6, BUTYRIC ACID WITH ZINC, AND OPTIONALLY RED CLOVER, TO REDUCE LIVER ABSCESSES IN CATTLE | Sep 30, 24 | Apr 03, 25 | Not available |
| 2025/0108,076 | METHODS FOR TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASES (NAFLD) USING ADVANCED MICROBIOME THERAPEUTICS | Apr 24, 23 | Apr 03, 25 | Not available |
| 2025/0109,154 | LYSOPHOSPHATIDYLSERINE ANALOGUE, AND LYSOPHOSPHATIDYLSERINE ANALOGUE-CONTAINING PHAMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING FIBROSIS | Jan 27, 23 | Apr 03, 25 | Japan as represented by President of the University of Tokyo |
| 2025/0099,383 | COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACIDS | Jan 20, 23 | Mar 27, 25 | Not available |
| 2025/0099,468 | TREATING LIVER DISORDERS WITH AN SSAO INHIBITOR | Dec 11, 24 | Mar 27, 25 | Not available |
| 2025/0100,983 | BENZOTHIA(DI)AZEPINE COMPOUNDS AND THEIR USE AS BILE ACID MODULATORS | Sep 25, 24 | Mar 27, 25 | Not available |
| 2025/0101,120 | ANTIBODIES SPECIFICALLY RECOGNIZING FASL AND USES THEREOF | Jan 16, 23 | Mar 27, 25 | Not available |
| 2025/0090,515 | 1-Deoxynojirimycin To Mitigate Hepatic Ischemia- Reperfusion | Sep 18, 23 | Mar 20, 25 | Not available |
| 2025/0090,606 | COMPOSITIONS FOR TREATMENT OF A FATTY LIVER OR FIBROTIC LIVER DISEASE | Jan 13, 23 | Mar 20, 25 | Not available |
| 2025/0092,403 | COMPOSITIONS AND METHODS FOR INHIBITING KETOHEXOKINASE (KHK) | Apr 22, 24 | Mar 20, 25 | Not available |
| 2025/0092,041 | PYRAZOLOPYRIDINE DERIVATIVE HAVING GLP-1 RECEPTOR AGONIST EFFECT | Nov 22, 24 | Mar 20, 25 | Chugai Seiyaku Kabushiki Kaisha |
| 2025/0092,126 | TREATMENT AND PREVENTION OF ALCOHOLIC LIVER DISEASE | Jul 26, 22 | Mar 20, 25 | Boehringer Ingelheim International GmbH |
| 2025/0082,616 | Solid Dispersion Forms of Rifaximin | Nov 25, 24 | Mar 13, 25 | Not available |
| 2025/0082,654 | AZD3355 (LESOGABERAN) FOR TREATMENT AND PREVENTION OF NONALCOHOLIC STEATOHEPATITIS (NASH), LIVER FIBROSIS, AND OTHER LIVER CONDITIONS | Sep 16, 24 | Mar 13, 25 | Icahn School of Medicine at Mount Sinai |
| 2025/0082,690 | SHEET-SHAPED CELL CULTURE FOR TREATING LIVER DYSFUNCTION | Jul 09, 24 | Mar 13, 25 | Not available |
| 2025/0082,706 | FERMENTED GINSENG RADIX ET RHIZOMA EXTRACT, PRODUCT FOR ALLEVIATING NON-ALCOHOLIC FATTY LIVER DISEASE, METHOD FOR PROMOTING INCREASE OF CONTENT OF AGLYCONE FLAVONOIDS AND/OR SHORT-CHAIN FATTY ACIDS IN GINSENG RADIX ET RHIZOMA EXTRACT, AND METHOD FOR PROMOTING EFFICACY OF GINSENG RADIX ET RHIZOMA EXTRACT IN ALLEVIATING NON-ALCOHOLIC FATTY LIVER DISEASE | Jun 18, 24 | Mar 13, 25 | INFINITUS (CHINA) COMPANY LTD. |
| 2025/0084,072 | GLP-1R MODULATING COMPOUNDS | Aug 20, 24 | Mar 13, 25 | Not available |
| 2025/0073,247 | MURICHOLIC ACIDS AND DERIVATIVES FOR CHOLESTASIS TREATMENT | Sep 03, 24 | Mar 06, 25 | Not available |